The precursor and standard compound
Ended Purchase Order Awarded
- Contract number
- HHSN268201800017PC
- Awardee
-
ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH UEI LAHNMPWWFFJ9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,950
Award facts
- Contract value 100% obligated
- $10,950.00 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN268201800017PC?
HHSN268201800017PC was awarded to ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH by National Heart Lung and Blood Institute (National Institutes of Health) on October 27, 2017.
How much is contract HHSN268201800017PC worth?
The government has obligated $10,950 on HHSN268201800017PC.
Was contract HHSN268201800017PC competed?
The extent of competition for HHSN268201800017PC was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award